Most Read Articles
Roshini Claire Anthony, 3 days ago

The presence of pulmonary arterial hypertension (PAH) in individuals with systemic sclerosis is associated with an increased mortality risk, a study from Singapore showed.

23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Stephen Padilla, 6 days ago
Brodalumab has exhibited long-term efficacy and consistent safety profile for more than 2 years in the treatment of patients with psoriasis, results of the phase III AMAGINE-2 trial show.
19 Jan 2020
Anaemia increases mortality risk in heart failure (HF) patients across the ejection fraction (EF) spectrum, a recent study has found. The effect appears to be stronger in preserved (HFpEF) and midrange (HFmrEF) than in reduced (HFrEF) EF disease.

Diabetes may be linked to environment quality

18 Oct 2019
In the first 10 days of May 2017 alone, air pollution reached ‘very high’ and ‘serious’ levels in six out of Hong Kong’s 13 monitoring stations.

Environmental quality and exposure to pollution may play a small part in the development of metabolic diseases, such as diabetes, a new study has found.

Using the Environmental Quality Index (EQI), researchers assessed multifactorial, county-level ambient environmental exposures. The information was then linked to county-level annual age-adjusted, population-based diabetes prevalence estimates. Obesity, leisure time and physical inactivity were included as covariates.

A total of 3,134 counties were represented in the analysis, of which 34.7 percent and 33.7 percent were metropolitan-urbanized and less-urbanized, respectively. On the other hand, 21.3 percent were thinly populated, while the remaining 10.3 percent of the counties were classified as nonmetropolitan urbanized. The mean total diabetes prevalence rate was 13.58±2.44 per 100,000 population.

Controlling for covariates, researchers found that in the overall sample, poor cumulative environmental quality correlated significantly with lower total diabetes prevalence (prevalence difference [PD], –1.36, 96 percent CI, –1.43 to –1.28). The same was true for diagnosed and undiagnosed diabetes.

However, stratifying according to rural-urban status revealed important differences. In less-urbanized (PD, 2.58. 2.46–2.71) and thinly populated (PD, 2.88, 2.74–3.01) counties, poor cumulative environmental quality significantly increased the prevalence of total diabetes. In metropolitan-urbanized areas, on the other hand, the correlation was null (PD, 0.07, –0.03 to 0.17).

Moreover, disaggregation according to EQI domains, and with respect to both domains and rural-urban status, further revealed variations in the interplay between environmental quality and the prevalence of diabetes. This suggests that further studies targeting specific interactions within this complex web are needed.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 3 days ago

The presence of pulmonary arterial hypertension (PAH) in individuals with systemic sclerosis is associated with an increased mortality risk, a study from Singapore showed.

23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Stephen Padilla, 6 days ago
Brodalumab has exhibited long-term efficacy and consistent safety profile for more than 2 years in the treatment of patients with psoriasis, results of the phase III AMAGINE-2 trial show.
19 Jan 2020
Anaemia increases mortality risk in heart failure (HF) patients across the ejection fraction (EF) spectrum, a recent study has found. The effect appears to be stronger in preserved (HFpEF) and midrange (HFmrEF) than in reduced (HFrEF) EF disease.